Wells Fargo & Company Antares Pharma, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	N/A	-151,406 Closed	0 $0
Q1 2022 May 16, 2022	SELL	N/A	-55,111 Reduced 26.69%	151,406 $621,000
Q4 2021 Feb 14, 2022	SELL	N/A	-456,910 Reduced 68.87%	206,517 $737,000
Q3 2021 Nov 15, 2021	BUY	N/A	112,719 Added 20.47%	663,427 $2.42 Million
Q2 2021 Aug 16, 2021	BUY	N/A	212,405 Added 62.79%	550,708 $2.4 Million
Q1 2021 May 13, 2021	SELL	N/A	-94,075 Reduced 21.76%	338,303 $1.39 Million
Q4 2020 Feb 09, 2021	BUY	N/A	49,974 Added 13.07%	432,378 $1.73 Million
Q3 2020 Nov 05, 2020	SELL	N/A	-15,019 Reduced 3.78%	382,404 $1.03 Million
Q2 2020 Aug 13, 2020	BUY	N/A	93,095 Added 30.59%	397,423 $1.09 Million
Q1 2020 May 14, 2020	BUY	N/A	304,328 New	304,328 $717,000

About Antares Pharma, Inc.

Ticker ATRS
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 170,042,000
Market Cap $951M

More about ATRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.